Search

Your search keyword '"Ismail Matalka"' showing total 4 results
Start Over Author "Ismail Matalka" Publisher pagepress publications
4 results on '"Ismail Matalka"'

1. Platelet Indices As Quality Markers For Remission in Patients With Leukemia

Author

Suleimman Al-Sweedan and Ismail Matalka

Subjects
Leukemia, Platelets Indices, Diseases of the blood and blood-forming organs, RC633-647.5
Abstract

The purpose of this study was to investigate whether platelet indices [mean platelet volume (MPV) and platelet distribution width (PDW)] could serve as surrogate marker for follow-up in patients with leukemia. Blood samples were obtained from 48 patients with leukemia at diagnosis before chemotherapy and at the time of remission (mean age: 17.92 years; 24 males and 24 females). We measured the blood platelet indices using an automated counter. MPV was higher at the time of remission, but it was not statistically significant. However, PDW was significantly lower (P

Published
2014

2. HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA

Author

Sofia Omari, Alhossain A. Khalafallah, Mahmoud Ayesh, Ismail Matalka, and Al- Raji Hadithi

Subjects
Malignant lymphoma, erythropoietin, anemia, ferritin, Diseases of the blood and blood-forming organs, RC633-647.5
Abstract

Anemia is a common finding in lymphoma. There are few data available regarding the erythropoietin (EPO) levels in conjunction with ferritin in lymphoma patients. We prospectively evaluated 55 patients diagnosed with malignant lymphoma during the period between November 2006 and March 2008 at King Abdullah University Teaching Hospital, Jordan. Our data showed that 74.4% of lymphoma patients were anemic. Furthermore, serum EPO and ferritin levels were higher in lymphoma patients compared with the healthy controls (P=0.001). The observed versus predicted EPO ratio showed also significantly higher levels in anemic lymphoma patients compared to healthy controls (p=0.03). There was an improvement in Hb level in lymphoma patients who were treated with at least 3-cycles of chemotherapy as compared with newly-diagnosed patients. An adequate increase of EPO levels was observed in anemic lymphoma patients and notably associated with higher ferritin levels and improvement of Hb (p

Published
2011
Full Text
View/download PDF

3. HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA

Author

Alhossain A. Khalafallah, Sofia Omari, Mahmoud Ayesh, Ismail Matalka, and Al- Raji Hadithi

Subjects
Malignant lymphoma, erythropoietin, anemia, ferritin, Diseases of the blood and blood-forming organs, RC633-647.5
Abstract

Anemia is a common finding in lymphoma. There are few data available regarding the erythropoietin (EPO) levels in conjunction with ferritin in lymphoma patients. We prospectively evaluated 55 patients diagnosed with malignant lymphoma during the period between November 2006 and March 2008 at King Abdullah University Teaching Hospital, Jordan. Our data showed that 74.4% of lymphoma patients were anemic. Furthermore, serum EPO and ferritin levels were higher in lymphoma patients compared with the healthy controls (P=0.001). The observed versus predicted EPO ratio showed also significantly higher levels in anemic lymphoma patients compared to healthy controls (p=0.03). There was an improvement in Hb level in lymphoma patients who were treated with at least 3-cycles of chemotherapy as compared with newly-diagnosed patients. An adequate increase of EPO levels was observed in anemic lymphoma patients and notably associated with higher ferritin levels and improvement of Hb (p

Published
2011

4. HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA

Author

Raji H. Al-Hadithi, Sofia Omari, Alhossain A Khalafallah, Ismail Matalka, and Mahmoud H. Ayesh

Subjects
medicine.medical_specialty, Anemia, medicine.medical_treatment, Ferritin levels, Gastroenterology, Malignant lymphoma, immune system diseases, hemic and lymphatic diseases, Internal medicine, medicine, Chemotherapy, biology, business.industry, lcsh:RC633-647.5, Hematology, lcsh:Diseases of the blood and blood-forming organs, medicine.disease, Lymphoma, Ferritin, Infectious Diseases, Erythropoietin, Immunology, biology.protein, Erythropoiesis, business, Malignant lymphoma, erythropoietin, anemia, ferritin, medicine.drug
Abstract

Anemia is a common finding in lymphoma. There are few data available regarding the erythropoietin (EPO) levels in conjunction with ferritin in lymphoma patients. We prospectively evaluated 55 patients diagnosed with malignant lymphoma during the period between November 2006 and March 2008 at King Abdullah University Teaching Hospital, Jordan. Our data showed that 74.4% of lymphoma patients were anemic. Furthermore, serum EPO and ferritin levels were higher in lymphoma patients compared with the healthy controls (P=0.001). The observed versus predicted EPO ratio showed also significantly higher levels in anemic lymphoma patients compared to healthy controls (p=0.03). There was an improvement in Hb level in lymphoma patients who were treated with at least 3-cycles of chemotherapy as compared with newly-diagnosed patients. An adequate increase of EPO levels was observed in anemic lymphoma patients and notably associated with higher ferritin levels and improvement of Hb (p

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results